Published September 23, 2014 | Version v1
Patent Open

Methods and compositions related to immunizing against Staphylococcal lung disease and conditions

Description

Embodiments of the invention include methods and compositions useful in a vaccination strategy capable of neutralizing HIa to provide immunoprotection against S. aureus pneumonia. In certain aspects the invention includes a HIa with reduced toxicity, represented by a recombinant mutant form of HIa (HlaH35L) in which histidine 35 is converted to leucine, which can be used to abrogate the productive assembly of the toxin and protect a subject from staphylococcal pneumonia.

Files

US8840906.pdf

Files (2.6 MB)

Name Size Download all
md5:765951ad89502b94b3217d4eea1446fd
2.6 MB Preview Download

Additional details

Identifiers

Patent application number
US 67559708 A
Patent number
US 2011/0027265 A1
Other
oai:uchicago.tind.io:8290

Dates

Patent filed
2008-08-29

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pediatrics, Medicine